684.1500 9.00 (1.33%)
NSE Nov 26, 2025 15:31 PM
Volume: 268.6K
 

ICICI Securities Limited
Krishna Institute of Medical Sciences’ (KIMS) Q2FY23 performance was slightly below our estimates. Revenues grew 13.8% QoQ to Rs5.6bn (I-Sec: Rs6bn) driven by higher occupancy and addition of beds in existing hospitals.
ICICI Securities Limited downgraded Krishna Institute of Medical Sciences Ltd. to Sell with a price target of 630.0 on 11 Nov, 2025.
More from Krishna Institute of Medical Sciences Ltd.
Recommended